High pretransplant HBV level predicts HBV reactivation after kidney transplantation in HBV infected recipients

Annals of Surgical Treatment and Research

Volumn 86, Issue 5, 2014, Pages 256-263

  Kim, Jong Man ^a   Park, Hyojun ^a   Jang, Hye Ryoun ^a   Park, Jae Berm ^a   Kwon, Choon Hyuck David ^a   Huh, Wooseong ^a   Lee, Joon Hyeok ^a   Kim, Sung Joo ^a   Joh, Jae Won ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

HBV reactivation; Hepatitis B virus; Kidney transplantation; YMDD mutation

Indexed keywords

EID: 84905013468     PISSN: 22886575     EISSN: 22886796     Source Type: Journal    
DOI: 10.4174/astr.2014.86.5.256     Document Type: Article

References (19)

1. Korean Association for the Study of the Liver. KASL Clinical Practice Guidelines: management of chronic hepatitis B. Clin Mol Hepatol 2012; 18: 109-62.
2. Kalia H, Fabrizi F, Martin P. Hepatitis B virus and renal transplantation. Transplant Rev (Orlando) 2011; 25: 102-9.
3. Ivanyi B. A primer on recurrent and de novo glomerulonephritis in renal allografts. Nat Clin Pract Nephrol 2008; 4: 446-57.
4. Aroldi A, Lampertico P, Montagnino G, Passerini P, Villa M, Campise MR, et al. Natural history of hepatitis B and C in renal allograft recipients. Transplantation 2005; 79: 1132-6.
5. Fabrizi F, Martin P, Dixit V, Kanwal F, Dulai G. HBsAg seropositive status and survival after renal transplantation: meta-analysis of observational studies. Am J Transplant 2005; 5: 2913-21.
6. Perrillo RP. Hepatitis B and renal transplantation: securing the sword of damocles. Hepatology 2002; 36: 1041-5.
7. Mathurin P, Mouquet C, Poynard T, Sylla C, Benalia H, Fretz C, et al. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 1999; 29: 257-63.
8. Ahn HJ, Kim MS, Kim YS, Kim SI, Huh KH, Ju MK, et al. Clinical outcome of renal transplantation in patients with positive pre-transplant hepatitis B surface antigen. J Med Virol 2007; 79: 1655-63.
9. Degos F, Lugassy C, Degott C, Debure A, Carnot F, Theirs V, et al. Hepatitis B virus and hepatitis B-related viral infection in renal transplant recipients: A prospective study of 90 patients. Gastroenterology 1988; 94: 151-6.
10. Parfrey PS, Forbes RD, Hutchinson TA, Beaudoin JG, Dauphinee WD, Hollomby DJ, et al. The clinical and pathological course of hepatitis B liver disease in renal transplant recipients. Transplantation 1984; 37: 461-6.
11. Tur-Kaspa R, Shaul Y, Moore DD, Burk RD, Okret S, Poellinger L, et al. The glucocorticoid receptor recognizes a specific nucleotide sequence in hepatitis B virus DNA causing increased activity of the HBV enhancer. Virology 1988; 167: 630-3.
12. Cheng AL, Hsiung CA, Su IJ, Chen PJ, Chang MC, Tsao CJ, et al. Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma. Hepatology 2003; 37: 1320-8.
13. Therret E, Pol S, Legendre C, Gagnadoux MF, Cavalcanti R, Kreis H. Low-dose recombinant leukocyte interferon-alpha treatment of hepatitis C viral infection in renal transplant recipients: A pilot study. Transplantation 1994; 58: 625-8.
14. Allen MI, Deslauriers M, Andrews CW, Tipples GA, Walters KA, Tyrrell DL, et al. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group. Hepatology 1998; 27: 1670-7.
15. Lai CL, Chien RN, Leung NW, Chang TT, Guan R, Tai DI, et al. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. N Engl J Med 1998; 339: 61-8.
16. Lok AS, Lai CL, Leung N, Yao GB, Cui ZY, Schiff ER, et al. Long-term safety of lamivudine treatment in patients with chronic hepatitis B. Gastroenterology 2003; 125: 1714-22.
17. European Association for the Study of the Liver. EASL clinical practice guidelines. Management of chronic hepatitis B. Gastroenterol Clin Biol 2009; 33: 539-54.
18. Marzano A, Gaia S, Ghisetti V, Carenzi S, Premoli A, Debernardi-Venon W, et al. Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence. Liver Transpl 2005; 11: 402-9.
19. Beckebaum S, Sotiropoulos GC, Klein CG, Broelsch CE, Saner F, Paul A, et al. Predictive factors of outcome in patients transplanted for hepatitis B. Transplantation 2009; 87: 872-81.